CA
NZ
UK
AU
IND
US
● Pharming is a rare-disease biopharma whose shares moved with sector momentum.
● Tenax is a sub-$2 clinical-stage micro-cap that trades heavily on sentiment.
● Vicore is a clinical-stage biopharmaceutical company whose shares reacted to sentiment.
● Verrica is a small-cap dermatology biopharma with a low share price.
● Exicure is a low-priced, clinical-stage biotechnology micro-cap.
● Coeptis is a clinical-stage micro-cap whose value rests on therapies still in development.
● The slide erased about $24 billion of market value, according to reports.
NewAmsterdam Pharma Company (NASDAQ:NAMS) shares were trading near their 52-week low at USD 21.50 on October 21, 2026, down 0.02%. The late-stage biopharmaceutical company announced a positive CHMP opinion for obicetrapib in July, reported a second quarter 2026 net loss of $64.1 million in …
PTC Therapeutics (NASDAQ:PTCT) shares were trading near their 52-week low at USD 62.78 on October 21, 2026, down 0.22%. The rare disease drugmaker filed its second quarter 2026 report on July 30, reporting a $50.0 million milestone from Novartis for starting a Phase 3 …
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) shares were trading near their 52-week low at USD 41.21 on October 21, 2026, down 0.05%. The biopharmaceutical company announced on October 19 that it will report third quarter 2026 results on October 29 and host a conference call the …
Please wait processing your request...